Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 10;34(7):899-904.
doi: 10.1016/j.vaccine.2016.01.001. Epub 2016 Jan 8.

Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries

Debra D Kristensen  1 , Tina Lorenson  2 , Kate Bartholomew  2 , Shirley Villadiego  2
Affiliations

Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries

Debra D Kristensen et al. Vaccine. .

Abstract

Introduction: This study captures the perspectives of stakeholders at multiple levels of the vaccine supply chain regarding their assessment of challenges with storing vaccines within recommended temperature ranges and their perceptions on the benefits of having vaccines with improved stability, including the potential short-term storage and transport of vaccines in a controlled-temperature chain.

Methods: Semi-structured interviews were undertaken with 158 immunization stakeholders in six countries. Interviewees included national decision-makers and advisors involved in vaccine purchasing decisions, national Expanded Programme on Immunization managers, and health and logistics personnel at national, subnational, and health facility levels.

Results: Challenges with both heat and freeze-exposure of vaccines were recognized in all countries, with heat-exposure being a greater concern. Conditions leading to freeze-exposure including ice build-up due to poor refrigerator performance and improper icepack conditioning were reported by 53% and 28% of participants, respectively. Respondents were interested in vaccine products with improved heat/freeze-stability characteristics. The majority of those involved in vaccine purchasing indicated they would be willing to pay a US$0.05 premium per dose for a freeze-stable pentavalent vaccine (68%) or a heat-stable rotavirus vaccine (59%), although most (53%) preferred not to pay the premium for a heat-stable pentavalent vaccine if the increased stability required changing from a liquid to a lyophilized product. Most respondents (73%) were also interested in vaccines labeled for short-term use in a controlled-temperature chain. The majority (115/158) recognized the flexibility this would provide during outreach or should cold-chain breaks occur. Respondents were also aware that possible confusion might arise and additional training would be required if handling conditions were changed for some, but not all vaccines.

Conclusion: Participating immunization stakeholders recognized the benefits of vaccine products with improved stability characteristics and of labeling vaccines for controlled-temperature chain use as a means to help address cold-chain issues in their immunization programs.

Keywords: Cold chain; Controlled-temperature chain; Thermostable; Vaccine stability.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Perceived concerns regarding vaccine temperature exposures reported by country.
Fig. 2
Fig. 2
Participants stating that exposure of vaccines to freezing temperatures occurs in their immunization program.
Fig. 3
Fig. 3
Potential sources of vaccine freeze-exposure reported by country.
See this image and copyright information in PMC

References

    1. Matthias D.M., Robertson J., Garrison M.M., Newland S., Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine. 2007;25(20):3980–3986. - PubMed
    1. Nelson C., Froes P., Van Dyck A.M., Chavarría J., Boda E., Coca A. Monitoring temperatures in the vaccine cold chain in Bolivia. Vaccine. 2007;25(3):433–437. - PubMed
    1. Guichard S., Hymbaugh K., Burkholder B., Diorditsa S., Navarro C., Ahmed S. Vaccine wastage in Bangladesh. Vaccine. 2010;28(3):858–863. - PubMed
    1. Murhekar M., Dutta S., Kapoor A.N., Bitragunta S., Dodum R., Ghosh P. Frequent exposure to suboptimal temperatures in vaccine cold-chain systems in India: results of temperature monitoring in 10 states. Bull World Health Org. 2013;91:906–913. - PMC - PubMed
    1. World Health Organization . 2014. Effective Vaccine Management (EVM) Initiative. Global Data Analysis 2010-2013. Available at: http://www.who.int/immunization/programmes_systems/supply_chain/evm/en/i....

Publication types